The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants is a research paper published in Cell Host & Microbe (2021). On theSindex it has a DataRank of 0. It has been cited 274 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P30 CA014236
NIDDK NIH HHS
Grant: R01 DK119795
NIGMS NIH HHS
Grant: R35 GM122465
NCI NIH HHS
Grant: U01 CA214300
NIDDK NIH HHS
Grant: R01 DK113136
National Institutes of Health
Grant: 7R35GM122465-06
Robust Control of the Stem Cell Niche
National Institutes of Health
Defense Advanced Research Projects Agency
FWCI
12.23
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Location and condition based reconstruction of colon cancer microbiome from human RNA sequencing data
Additional file 1 of Location and condition based reconstruction of colon cancer microbiome from human RNA sequencing data
Additional file 1 of Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU
Additional file 1 of Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU
Additional file 2 of Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU
Additional file 2 of Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU
Additional file 3 of Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU
Additional file 3 of Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU
Additional file 4 of Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU
Additional file 4 of Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU
Additional file 5 of Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU
Additional file 5 of Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU
Additional file 3 of Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study
Additional file 1 of Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study
Additional file 3 of Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study
Additional file 2 of Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study
Additional file 1 of Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study
Additional file 2 of Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study